Provided by Tiger Fintech (Singapore) Pte. Ltd.

Silence Therapeutics Plc

2.30
-0.0800-3.36%
Post-market: 2.300.00000.00%16:05 EDT
Volume:209.95K
Turnover:515.19K
Market Cap:108.62M
PE:-2.35
High:2.90
Open:2.47
Low:2.28
Close:2.38
Loading ...

Silence Therapeutics FY EPS $(0.33) Up From $(0.49) YoY, Sales $43.26M Up From $31.64M YoY

Benzinga
·
27 Feb

Press Release: Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Dow Jones
·
27 Feb

Eramet confirms its resilience and successfully delivers on its strategic roadmap

GlobeNewswire
·
20 Feb

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading

MT Newswires Live
·
19 Feb

Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025

Business Wire
·
13 Feb

Silence Therapeutics Shares Fall After Goldman Sachs Initiates Coverage at Sell

MT Newswires Live
·
12 Feb

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
12 Feb

Goldman Sachs Initiates Silence Therapeutics at Sell With $6 Price Target

MT Newswires Live
·
11 Feb

European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading

MT Newswires Live
·
04 Feb

Silence management enthusiastic ahead of catalysts, says H.C. Wainwright

TIPRANKS
·
30 Jan

European Equities Traded in the US as American Depositary Receipts Tread Water in Monday Trading

MT Newswires Live
·
28 Jan

European Equities Traded in the US as American Depositary Receipts Rise Thursday

MT Newswires Live
·
17 Jan

Institutional owners may take dramatic actions as Silence Therapeutics plc's (NASDAQ:SLN) recent 14% drop adds to one-year losses

Simply Wall St.
·
10 Jan

European Equities Traded in US as American Depositary Receipts Surge on Monday

MT Newswires Live
·
07 Jan